Access To Birth Control Worldwide Inadequate

20 April 1997

Contraceptive choice is fundamental to women's health, according to anew study published by Population Action International, which noted that the lack of access to birth control is an obstacle to the improvement of women's health. Although progress has been made over the past 15 years, large gaps remain, the study noted. More than 100 million married women worldwide have an unmet need for contraception, and even those with some access have few choices about what methods are available.

In some countries sterilization is relatively easy to obtain, but access to reversible contraceptives is limited, the study notes. It also points out that the rate of abortion dropped in countries where access to contraception has improved, such as Chile, Colombia, Hungary and South Korea, as well as Russia, Kazakhstan and the Ukraine.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight